Dropping antipsychotic polypharmacy looks safe, effective when 1 drug is clozapine or an injectable

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Patients receiving clozapine (Clozaril, FazaClo, Versacloz) or a long-acting injectable antipsychotic experienced no worsening of symptoms or side effects when switched to monotherapy.
  • Patients who switched to oral, nonclozapine antipsychotic (NCAP) experienced reduced side effec...